Australia markets close in 3 hours 27 minutes
  • ALL ORDS

    7,066.90
    +24.20 (+0.34%)
     
  • ASX 200

    6,809.60
    +20.00 (+0.29%)
     
  • AUD/USD

    0.7759
    -0.0018 (-0.23%)
     
  • OIL

    60.07
    -0.57 (-0.94%)
     
  • GOLD

    1,716.50
    -6.50 (-0.38%)
     
  • BTC-AUD

    63,113.16
    +3,065.00 (+5.10%)
     
  • CMC Crypto 200

    980.52
    +52.29 (+5.63%)
     
  • AUD/EUR

    0.6445
    -0.0005 (-0.08%)
     
  • AUD/NZD

    1.0686
    -0.0005 (-0.04%)
     
  • NZX 50

    12,398.93
    +97.12 (+0.79%)
     
  • NASDAQ

    13,282.95
    +373.51 (+2.89%)
     
  • FTSE

    6,588.53
    +105.10 (+1.62%)
     
  • Dow Jones

    31,535.51
    +603.14 (+1.95%)
     
  • DAX

    14,012.82
    +226.53 (+1.64%)
     
  • Hang Seng

    29,452.57
    0.00 (0.00%)
     
  • NIKKEI 225

    29,745.24
    +81.74 (+0.28%)
     

Global Digitizing Healthcare Market Report 2021-2028: Assessment of Healthcare Use Cases and Technology that will Digitize Patient Healthcare

Research and Markets
·3-min read

Dublin, Jan. 27, 2021 (GLOBE NEWSWIRE) -- The "Digitizing Healthcare: Data, Diagnostics and Devices" report has been added to ResearchAndMarkets.com's offering.

This report provides an assessment of healthcare use cases and technology that will digitize patient healthcare. It includes analysis of how digital devices digitalize, transform and improve patient healthcare and medical services. It also includes forecasts from 2021 through 2028.

Digital Medical devices use various IT technologies (IoT, cloud, AI, robotics, big data) to provide new or enhanced medical applications and services. In certain cases, it is the medical application that provides the intelligence to drive the device. However, we do not necessarily see a need for digital devices to have onboard intelligence, as the device could be controlled remotely by centralized intelligence in a cloud-based framework to make decisions, and/or take action.

The initial healthcare use case, health tracker, uses wearable devices, in the form of wristwatches, to allow users to monitor and track their exercise/physical activity through a mobile application. These devices are FDA unregulated devices (no regulatory control and are not intended to help support or sustain life) and not considered accurate enough for medical diagnosis.

These new healthcare services will be used to improve medical data analytics and diagnosis, improving data interpretations while reducing analysis time of all data outputs. This provides the industry capabilities to improve productivity, save costs and improve patient services and care. Other benefits include improved money management and lower costs and investments.

Target Audience:

  • Application Developers

  • Cloud and Internet of Things Companies

  • Data Analytics Companies

  • Electronics Manufacturers

  • Governmental Organizations and NGOs

  • Hospitals, Clinics and Diagnostic Centers

  • Managed Services Companies

  • Management Consultants

  • Smart Device Providers

  • Systems Integrators

Report Benefits:

  • Digitizing healthcare 2021 - 2028

  • Identify the market leaders in digitizing healthcare

  • Identify digitizing healthcare use cases and applications

  • Learn about future emerging digitizing healthcare solutions

  • Understand the role and importance of wearables in healthcare

Key Topics Covered:

1. Introduction

2. Digitize Healthcare Use Cases

3. Clinical Data Management
3.1. GE Healthcare
3.2. Masimo
3.3. Siemens
3.4. Tempus

4. Digital Health Monitoring Devices
4.1. AliveCor
4.2. BioTelemetry
4.3. Dexacon
4.4. FitBit
4.5. GE Healthcare
4.6. Masimo

5. Digital Health Diagnostic Tools
5.1. Abbott Laboratories
5.2. AliveCor
5.3. Babylon Health
5.4. BioTelemetry
5.5. Boston Scientific
5.6. Cardiac insight
5.7. Dexacon
5.8. GE Healthcare
5.9. K Health
5.10. iRhythm
5.11. Masimo
5.12. Medtronics
5.13. Siemens
5.14. Thermo Fisher

6. Digital Device Medicine Dispensing
6.1. Angiodynamics
6.2. Baxter International
6.3. Insulet
6.4. Tandem

7. Digital Therapeutic Devices
7.1. Abbott Laboratories
7.2. Pear Therapeutics
7.3. ResMed

8. Radiotherapy Oncology
8.1. Accuray
8.2. Varian

9. Robotic-assisted Surgery
9.1. Intuitive
9.2. Medtronics
9.3. Transenterix

10. Future Healthcare Products
10.1. Affectiva
10.2. Basehealth
10.3. BioDirection
10.4. IBM/Medtronics

11. Healthcare Devices Issues and Risks

12. Overall Healthcare Issues and Risks

13. Summary of Patient Benefits

14. Forecasts

15. Conclusions

For more information about this report visit https://www.researchandmarkets.com/r/159li2

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900